A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.
Alkema M, Smit MJ, Marin-Mogollon C, Totté K, Teelen K, van Gemert GJ, van de Vegte-Bolmer M, Mordmüller BG, Reimer JM, Lövgren-Bengtsson KL, Sauerwein RW, Bousema T, Plieskatt J, Theisen M, Jore MM, McCall MBB.
Alkema M, et al. Among authors: smit mj.
BMC Med. 2024 Apr 23;22(1):170. doi: 10.1186/s12916-024-03379-y.
BMC Med. 2024.
PMID: 38649867
Free PMC article.
Clinical Trial.